Hypertelorism-microtia-facial clefting syndrome

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:2213OMIM:239800Q87.0
Who is this for?
Show terms as
8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Hypertelorism-microtia-facial clefting syndrome (also known as HMC syndrome or Bixler syndrome) is an extremely rare congenital malformation syndrome characterized by a distinctive combination of craniofacial anomalies present at birth. The hallmark features include hypertelorism (widely spaced eyes), microtia (underdeveloped or malformed ears), and facial clefting, which may involve cleft lip, cleft palate, or both. Additional features that have been reported in affected individuals include conductive hearing loss related to the ear malformations, renal anomalies, and congenital heart defects, indicating that the syndrome can affect multiple organ systems beyond the craniofacial structures. The condition was first described by Bixler and colleagues, and only a small number of cases have been reported in the medical literature. Some familial cases have been observed, suggesting a genetic basis, though the precise molecular cause has not been definitively established. The pattern of inheritance has been suggested to be autosomal recessive based on reports of affected siblings born to unaffected parents, though this remains to be fully confirmed. Treatment is symptomatic and supportive, focusing on surgical correction of facial clefts, reconstructive surgery for ear malformations, hearing aids or other interventions for hearing loss, and monitoring and management of any associated renal or cardiac anomalies. A multidisciplinary team including craniofacial surgeons, otolaryngologists, audiologists, cardiologists, and nephrologists is typically involved in the care of affected individuals. Genetic counseling is recommended for affected families.

Also known as:

Clinical phenotype terms— hover any for plain English:

Median cleft palateHP:0009099Thenar muscle atrophyHP:0003393Crossed fused renal ectopiaHP:0004736Bifid nasal tipHP:0000456Bifid noseHP:0011803
Inheritance

Autosomal recessive

Passed on when both parents carry the same gene change; often skips generations

Age of Onset

Neonatal

Begins at or shortly after birth (first 4 weeks)

Orphanet ↗OMIM ↗NORD ↗

Treatments

No FDA-approved treatments are currently listed for Hypertelorism-microtia-facial clefting syndrome.

View clinical trials →

No actively recruiting trials found for Hypertelorism-microtia-facial clefting syndrome at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the Hypertelorism-microtia-facial clefting syndrome community →

No specialists are currently listed for Hypertelorism-microtia-facial clefting syndrome.

View NORD Rare Disease Centers ↗Undiagnosed Disease Network ↗

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Hypertelorism-microtia-facial clefting syndrome.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Hypertelorism-microtia-facial clefting syndromeForum →

No community posts yet. Be the first to share your experience with Hypertelorism-microtia-facial clefting syndrome.

Start the conversation →

Latest news about Hypertelorism-microtia-facial clefting syndrome

No recent news articles for Hypertelorism-microtia-facial clefting syndrome.

Follow this condition to be notified when news becomes available.

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Common questions about Hypertelorism-microtia-facial clefting syndrome

What is Hypertelorism-microtia-facial clefting syndrome?

Hypertelorism-microtia-facial clefting syndrome (also known as HMC syndrome or Bixler syndrome) is an extremely rare congenital malformation syndrome characterized by a distinctive combination of craniofacial anomalies present at birth. The hallmark features include hypertelorism (widely spaced eyes), microtia (underdeveloped or malformed ears), and facial clefting, which may involve cleft lip, cleft palate, or both. Additional features that have been reported in affected individuals include conductive hearing loss related to the ear malformations, renal anomalies, and congenital heart defects

How is Hypertelorism-microtia-facial clefting syndrome inherited?

Hypertelorism-microtia-facial clefting syndrome follows a autosomal recessive inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.

At what age does Hypertelorism-microtia-facial clefting syndrome typically begin?

Typical onset of Hypertelorism-microtia-facial clefting syndrome is neonatal. Age of onset can vary across affected individuals.